Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
TheraCryf financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
£0
2024-06-25
Market Capitalization
£3.4 M
2024-06-25
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 194.0K | 422.0K | 396.0K | |||||
| Gross profit | 194.0K | 422.0K | 396.0K | 34.0K | ||||
| Gross profit margin, % | 100.0% | 100.0% | 100.0% | |||||
| Operating expense total | 3.0M | 3.1M | 3.1M | 3.4M | 3.2M | 5.5M | 3.9M | 2.0M |
| Depreciation and amortization | 21.0K | 21.0K | 21.0K | 18.0K | 16.0K | 13.0K | 11.0K | 70.0K |
| EBITDA | (3.0M) | (3.1M) | (3.1M) | (3.2M) | (3.2M) | (5.1M) | (3.5M) | (2.0M) |
| EBITDA margin, % | -1642.3% | -1198.3% | -896.2% | |||||
| EBIT | (3.0M) | (3.1M) | (3.1M) | (3.2M) | (3.2M) | (5.1M) | (3.6M) | (2.1M) |
| EBIT margin, % | -1651.5% | -1201.4% | -899.0% | |||||
| Interest income | 24.0K | 98.0K | 5.0K | |||||
| Pre tax profit | (3.0M) | (3.1M) | (3.2M) | (3.2M) | (3.2M) | (5.0M) | (3.6M) | (2.1M) |
| Income tax expense | (443.0K) | (496.0K) | (451.0K) | (539.0K) | (439.0K) | (963.0K) | (429.0K) | (144.0K) |
| Net Income | (2.6M) | (2.6M) | (2.7M) | (2.7M) | (2.7M) | (4.0M) | (3.1M) | (1.9M) |